Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two Year Prospective, Interventional Single-Centre Trial
figure
posted on 2020-06-16, 08:30 authored by Praveen J Patel, Hari Jayram, Maria Eleftheriadou, Clara Vazquez-Alfageme, Niaz Islam, Gary S Rubin, Bish Pal, Peter K Addison, Robin Hamilton, Simona Degli EspostiThe above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
